Skip to content
2000
Volume 1, Issue 4
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Lipopolysaccharide (LPS) induced Gram-negative sepsis and septic shock remain lethal in up to 60 percent of cases, and LPS antagonists that neutralize its endotoxic action are the subject of intensive research. In the last decade peptidic antagonists have become increasingly important in providing leads for treatment of LPS-mediated diseases. In this review an overview of the sources, functions and structures of antiseptic and antibacterial peptides that interact with LPS is presented.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557013406729
2001-11-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557013406729
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test